Startups
Exela Pharma Sciences is an emerging specialty pharmaceutical company that focuses on developing, manufacturing and marketing generic and proprietary injectable and sterile ophthalmic products. They pride themselves on developing and marketing high quality pharmaceutical products in the sterile injectable arena. Their products are manufactured to the highest standards, following strict cGMP processes that help them ensure they meet or exceed all regulatory standards.
and 11 Leading Health Systems have invested in Exela Pharma Sciences to secure and support U.S.-based drug supply and manufacturing.
and 11 Leading Health Systems have invested in Exela Pharma Sciences to secure and support U.S.-based drug supply and manufacturing.
Overview
Location
United States, North Carolina, Lenoir
Employees
201-500
Founded date
2005
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 6
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 1, 2024 | Recipharm and Exela announce exclusive strategic alliance | Recipharm and Exela announce exclusive strategic alliance Tue, Oct 01, 2024 09:00 CET Report this content Sterile manufacturing capability in the US with over 100 million readily-available units (including vials and Pre-Filled Syringes – PF... |
| Jun 24, 2024 | Exela Technologies Announces $35 Million Breach Remediation Notification Contract Win | IRVING, Texas, June 24, 2024 (GLOBE NEWSWIRE) -- Exela Technologies, Inc. (“Exela” or “the Company”) (NASDAQ: XELA, XELAP), a global business process automation (“BPA”) leader, today announced a contract win valued at over $35 million. The ... |
| Apr 28, 2023 | Exela Technologies Announces Estimated $48M TCV Win | |
| Mar 2, 2023 | Exela Technologies Announces New Funding, Amendment Increases Existing Securitization Facility to $185 Million and Other Related Transactions | |
| Sep 8, 2021 | UHS Signs On: Premier Inc. and 11 Leading Health Systems Invest in Exela Pharma Sciences to Secure and Support US-based Drug Supply | CHARLOTTE, N.C. (September 8, 2021) - Premier Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, and 11 leading health systems acquired a minority stake in Exela Holdings, Inc., the holding company of Exela® Ph... |
Reviews 0
FAQ about Exela
When was Exela founded?
Exela was founded in 2005.
What has the press written about Exela?
Parsers VC has collected 6 articles mentioning Exela, among them “Recipharm and Exela announce exclusive strategic alliance” (Oct 1, 2024) and “Exela Technologies Announces $35 Million Breach Remediation Notification Contract Win” (Jun 24, 2024).
Is Exela still active?
Exela is probably closed: its latest activity on Parsers VC dates from Oct 1, 2024.